Volume 17, Issue 1 (8-2023)                   Qom Univ Med Sci J 2023, 17(1): 24-35 | Back to browse issues page

Ethics code: IR.IAU.FALA.REC.1399.061


XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Aboutalebi A, Mohammadi-Sichani M, Naghavi N. Detection of Brucella militensis in the Serum of Patients Suspected of Brucellosis by the Omp31 Gene Amplification, Compared to the Serological Diagnostic Tests. Qom Univ Med Sci J 2023; 17 (1) : 44.4
URL: http://journal.muq.ac.ir/article-1-3624-en.html
1- Department of Microbiology, Faculty of Biological Sciences, Falavarjan Branch, Islamic Azad University, Isfahan, Iran.
2- Department of Microbiology, Faculty of Biological Sciences, Falavarjan Branch, Islamic Azad University, Isfahan, Iran. , Ma.Mohammadi1347@iau.ac.ir
Full-Text [PDF 4049 kb]   (473 Downloads)     |   Abstract (HTML)  (1255 Views)
Full-Text:   (477 Views)
Introduction
Brucellosis is a widespread zoonotic disease transmitted from animals to humans. Although it cannot be transmitted from human to human, it can be acquired through direct contact with infected animals or consumption of unpasteurized and raw dairy products. Different species of Brucella can cause disease in humans, but the most prevalent one is Brucella melitensis. Blood culture is considered the gold standard for the laboratory diagnosis of brucellosis, but it has limitations such as requiring specialized culture media, level 3 biological safety, and trained personnel, and has a high false negative rate. Alternative diagnostic methods are serological tests, such as Rose Bengal, serum agglutination, and Coombs test, which are based on the reaction of antibodies against the smooth lipopolysaccharide of the bacterial wall. However, these tests can produce false positive results. Molecular detection techniques have shown to be effective in detecting Brucella species. Brucella-specific proteins, especially the third group of outer membrane proteins, including Omp25 and Omp31, have been used in serological and molecular tests. The Omp31 protein is highly conserved in Brucella species and plays an essential role in stimulating CD8+ T and CD4+ T cells, with its antibody against B. melitensis detected in infected individuals. Using purified and recombinant Omp31 protein, it is possible to detect B. melitensis in the serum of humans and animals with brucellosis using an ELISA kit. The present study aims to use the gene encoding Omp31 for specific molecular detection of B. melitensis in the serum of patients.
Methods
Participants were 200 people suspected of having brucellosis, who had been referred to medical diagnostic laboratories in Isfahan, Iran. After completing a questionnaire and consent form, blood samples were divided into two separate tubes, one with heparin for polymerase chain reaction (PCR) and one without heparin for serum separation and serological tests. Molecular detection using PCR was performed with specially designed primers for precise and final identification of Brucella. DNA extraction was carried out using the phenol/chloroform extraction method. Primers were designed using the Omp31 gene sequence from B. melitensis bacterium with accession number NG-021140.1 obtained from the NCBI database, and synthesized with a melting temperature of 54 degrees Celsius. The forward (5’-GTGGTGTTCAGGCCGGTTAC-3’) and reverse (5’-CGCAGACTTGACCTTACCATAG-3’) primers were used.
Results
This study examined 200 blood samples from 122 women and 78 men with a mean age of 45.17±17.43 years. Brucellosis was most prevalent in middle-aged patients aged 30-60 (56.5%), housekeepers (41.5%), and urban residents (75.5%). Clinical symptom analysis revealed that muscle pain (68%) was the most common symptom in women, while leg pain (62.3%) was most frequent in men. The PCR test for the Omp31 gene was positive in 14.5% of cases, which was consistent with the results obtained from serological tests (13.8%). Sensitivity of Wright test, Coombs-Wright test, 2-mercaptoethanol (2ME) test, and gel agglutination test, compared to PCR, was 89.7%, 75.9%, 55.2%, and 55.2%, respectively. The highest risk factor for patients was consumption of non-pasteurized dairy products (17%).
Conclusion
The PCR method is a fast and accurate technique for detecting brucellosis, with many advantages over traditional culture-based methods. It has no limitations related to culture methods and can diagnose the disease in less than one day. It has high sensitivity and repeatability, and poses a lower risk to workers. In this study, 29 out of 200 suspected Brucella samples (13%) tested positive using PCR with primers binding to the Omp31 gene. These findings demonstrate the accuracy and reliability of PCR for bacterial identification. The PCR technique also allows for rapid detection and differentiation of different Brucella species.
Nucleic acid tests such as PCR are considered as next-generation technologies with higher sensitivity than blood culture method and better specificity than serological tests for detecting brucellosis. Gershasbi et al. (2014) reported that the sensitivity and specificity of PCR for detecting brucellosis were 96% and 80.7%, respectively, which is consistent with the findings of this study. Overall, the use of PCR as a diagnostic method for brucellosis is recommended due to its high accuracy and being time effective. The PCR method has a sensitivity and specificity of 98%, which is much higher than other diagnostic methods.
The demographic study of brucellosis diagnosed by PCR in this study is consistent with previous studies in terms of age groups, occupation, and risk factors associated with the disease. However, unlike most previous studies where the prevalence of brucellosis in men was reported higher than in women, the prevalence of brucellosis in women was higher in this study. This finding suggests the need to investigate the cause of the increased incidence of brucellosis in Iranian women. In addition, public health measures such as promoting the use of pasteurized dairy products should be emphasized to prevent the transmission of brucellosis.
Ethical Considerations
Compliance with ethical guidelines
This study was approved by the Ethics Committee of Falavarjan Branch, Islamic Azad University (Code: IR.IAU.FALA.REC.1399.061).
Funding
This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors
Authors contributions
All authors contributed equally to preparing this paper.
Conflicts of interest
The authors declared no conflict of interest.
Acknowledgements
The authors would like to thank the official of the Microbiology Laboratory, Falavarjan Branch, Islamic Azad University.

 
Type of Study: Original Article | Subject: میکروب شناسی
Received: 2022/12/9 | Accepted: 2023/03/25 | Published: 2023/08/1

References
1. Tulu D. Bovine brucellosis: Epidemiology, public health implications, and status of brucellosis in Ethiopia. Vet Med. 2022; 13:21-30. [DOI:10.2147/VMRR.S347337] [PMID] [PMCID] [DOI:10.2147/VMRR.S347337]
2. Kydyshov K, Usenbaev N, Sharshenbekov A, Aitkuluev N, Abdyraev M, Chegirov S, et al. Brucellosis in humans and animals in Kyrgyzstan. Microorganisms. 2022; 10(7):1293. [DOI:10.3390/microorganisms10071293] [PMID] [PMCID] [DOI:10.3390/microorganisms10071293]
3. Golshani M, Buozari S. A review of brucellosis in Iran: Epidemiology, risk factors, diagnosis, control, and prevention. Iran Biomed J. 2017; 21(6):349-59. [DOI:10.18869/acadpub.ibj.21.6.349] [PMID] [PMCID]
4. Głowacka P, Żakowska D, Naylor K, Niemcewicz M, Bielawska-Drózd A. Brucella - virulence factors, pathogenesis and treatment. Pol J Microbiol. 2018; 67(2):151-61. [DOI:10.21307/pjm-2018-029] [PMID] [PMCID] [DOI:10.21307/pjm-2018-029]
5. Waktole H, Aden M, Ashenafi H. Seroepidemiology of camel brucellosis in and around Dire Dawa, Eastern Ethiopia. Vet Med Int. 2022; 2022:6624293. [DOI:10.1155/2022/6624293] [PMID] [PMCID] [DOI:10.1155/2022/6624293]
6. Lukambagire AS, Mendes ÂJ, Bodenham RF, McGiven JA, Mkenda NA, Mathew C, et al. Performance characteristics and costs of serological tests for brucellosis in a pastoralist community of northern Tanzania. Sci Rep. 2021; 11(1):5480. [DOI:10.1038/s41598-021-82906-w] [PMID] [PMCID] [DOI:10.1038/s41598-021-82906-w]
7. Ma X, Sun GQ, Wang ZH, Chu YM, Jin Z, Li BL. Transmission dynamics of brucellosis in Jilin province, China. Commun Nonlinear Sci Numer Simul. 2022; 114:106702. [DOI:10.1016/j.cnsns.2022.106702] [DOI:10.1016/j.cnsns.2022.106702]
8. Trotta A, Marinaro M, Cirilli M, Sposato A, Adone R, Beverelli M, et al. Brucella melitensis B115-based ELISA to unravel false positive serologic reactions in bovine brucellosis: A field study. BMC Vet Res. 2020; 16(1):50. [DOI:10.1186/s12917-020-02278-7] [PMID] [PMCID] [DOI:10.1186/s12917-020-02278-7]
9. Cassataro J, Pasquevich K, Bruno L, Wallach JC, Fossati CA, Baldi PC. Antibody reactivity to Omp31 from Brucella melitensis in human and animal infections by smooth and rough Brucellae. Clin Diagn Lab Immunol. 2004; 11(1):111-4. [DOI:10.1128/CDLI.11.1.111-114.2004] [PMID] [PMCID] [DOI:10.1128/CDLI.11.1.111-114.2004]
10. Bulashev AK, Ingirbay BK, Mukantayev KN, Syzdykova AS. Evaluation of chimeric proteins for serological diagnosis of brucellosis in cattle. Vet World. 2021; 14(8):2187-96.[DOI:10.14202/vetworld.2021.2187-2196] [PMID] [PMCID] [DOI:10.14202/vetworld.2021.2187-2196]
11. Erfanian M, Seyyed Nouzadi SM, Jarahi L. Evaluation of diagnostic sensitivity of wright, coombs wright and 2-Mercapto Ethanol in diagnosis of brucellosis. Evidence Based Care. 2013; 2(4):69-74. [DOI:10.22038/ebcj.2013.488]
12. Haghdoost M, Ansari L, Owaysee Osquee H. Brucellacapt test, wright and coombs wright in diagnosis of brucellosis. J Res Clin Med. 2021; 9(15):1-5. [DOI:10.34172/jrcm.2021.0015] [DOI:10.34172/jrcm.2021.0015]
13. Borsa BA, Aldag ME, Yilmaz M, Dalar ZG, Ozalp VC. Comparison of a novel test (ODAK brucella coombs gel test) with commonly used serological tests in human brucellosis. Clin Lab. 2016; 62(9):1671-4. [DOI:10.7754/Clin.Lab.2016.160120] [PMID] [DOI:10.7754/Clin.Lab.2016.160120]
14. Wang Y, Wang Z, Zhang Y, Bai L, Zhao Y, Liu C, et al. Polymerase chain reaction-based assays for the diagnosis of human brucellosis. Ann Clin Microbiol Antimicrob. 2014; 13:31. [DOI:10.1186/s12941-014-0031-7] [PMID] [PMCID] [DOI:10.1186/s12941-014-0031-7]
15. Moulana Z, Roushan MR, Marashi SM. Evaluation of different primers for detection of brucella by using PCR method. Electron Physician. 2016; 8(11):3222-7. [DOI:10.19082/3222] [PMID] [PMCID] [DOI:10.19082/3222]
16. Delam H, Keshtkaran Z, Rezaei B, Soufi O, Bazrafshan MR. Changing patterns in epidemiology of brucellosis in the south of Iran (2015-2020): Based on cochrane-armitage trend test. Ann Glob Health. 2022; 88(1):11. [DOI:10.5334/aogh.3474] [PMID] [PMCID] [DOI:10.5334/aogh.3474]
17. Adabi M, Karami M, Keramat F, Alikhani MY, Bakhtiari S. Serological and molecular investigation of human brucellosis in participants of Famenin brucellosis cohort study, Hamadan, Iran. Iran J Microbiol. 2021; 13(3):319-24. [DOI:10.18502/ijm.v13i3.6394] [PMID] [PMCID] [DOI:10.18502/ijm.v13i3.6394]
18. Di Bonaventura G, Angeletti S, Ianni A, Petitti T, Gherardi G. Microbiological laboratory diagnosis of human brucellosis: An overview. Pathogens. 2021; 10(12):1623. [DOI:10.3390/pathogens10121623] [PMID] [PMCID] [DOI:10.3390/pathogens10121623]
19. Al Dahouk S, Nöckler K. Implications of laboratory diagnosis on brucellosis therapy. Expert Rev Anti Infect Ther. 2011; 9(7):833-45. [DOI:10.1586/eri.11.55] [PMID] [DOI:10.1586/eri.11.55]
20. Dadar M, Alamian S, Behrozikhah AM, Yazdani F, Kalantari A, Etemadi A, et al. Molecular identification of brucella species and biovars associated with animal and human infection in Iran. Vet Res Forum. 2019; 10(4): 315-21. [DOI:10.30466/vrf.2018.89680.2171] [PMID] [PMCID]
21. Garshasbi M, Ramazani A, Sorouri R, Javani S, Moradi S. Molecular detection of Brucella species in patients suspicious of Brucellosis from Zanjan, Iran. Braz J Microbiol. 2014; 45(2):533-8. [DOI:10.1590/S1517-83822014005000048] [PMID] [PMCID] [DOI:10.1590/S1517-83822014005000048]
22. Zeinali A. [A review on the serological and allergical diagnostic methods of brucellosis (Persian)]. Vet Res Bio Pro. 1994; 7(1):145-7. [Link]
23. Hamzavi Y, Khademi N, Ghazi Zadeh MM, Janbakhsh A. [Epidemiology of malt fever in Kermanshah province in 2011 (Persian)]. J Kermanshah Uni Med Sci. 2014; 18(2):e74170. [DOI:10.22110/jkums.v18i2.1604]
24. Amro A, Mansoor B, Hamarsheh O, Hjaija D. Recent trends in human brucellosis in the West Bank, Palestine. Int J Infect Dis. 2021; 106:308-313. [DOI:10.1016/j.ijid.2021.04.037] [PMID] [DOI:10.1016/j.ijid.2021.04.037]
25. Mohammadian M, Salehiniya H, Kazaei S, Ramazanpour J, Mohammadian-Hafshejani A. [Epidemiological characteristics and incidence rate of brucellosis in Isfahan Province, Iran, 2012 (Persian)]. J Isfahan Med Sch. 2015; 33(355):1784-95. [Link]
26. Soodejani Taheri M, Lotfi M, Ghaderi A, Reisi A, Mohannadzadeh M. [Epidemiology of brucellosis in Shahr-e- Kord during the years 2010 to 2014 (Persian)]. Pars J Med Sci. 2016; 14(1):1-7. [DOI:10.29252/jmj.14.1.1] [DOI:10.29252/jmj.14.1.1]
27. Lai S, Chen Q, Li Z. Human brucellosis: An ongoing global health challenge. China CDC Wkly. 2021; 3(6):120-3.[DOI:10.46234/ccdcw2021.031] [PMID] [PMCID]
28. Saadat S, Mardaneh J, Ahouran M, Mohammadzadeh A, Ardebili A, Yousefi M, et al. Diagnosis of cattle brucellosis by PCR and serological methods: Comparison of diagnostic tests. Biomed Pharmacol J. 2017; 10(2):881-8. [DOI:10.13005/bpj/1181] [DOI:10.13005/bpj/1181]
29. Allen AR, Milne G, Drees K, Presho E, Graham J, McAdam P, et al. Genomic epizootiology of a Brucella abortus outbreak in Northern Ireland (1997-2012). Infect Genet Evol. 2020; 81:104235. [DOI:10.1016/j.meegid.2020.104235] [PMID] [DOI:10.1016/j.meegid.2020.104235]
30. O'Callaghan D. Human brucellosis: Recent advances and future challenges. Infect Dis Poverty. 2020; 9(1):101.[DOI:10.1186/s40249-020-00715-1] [PMID] [PMCID] [DOI:10.1186/s40249-020-00715-1]

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2026 CC BY-NC 4.0 | Qom University of Medical Sciences Journal

Designed & Developed by : Yektaweb